查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1933331

全球脑植入市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析、未来预测（2026-2034）

Brain Implants Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 180 Pages | 商品交期: 请询问到货日

价格

脑植入市场成长因素

由于神经系统疾病盛行率的上升、先进神经调控疗法的广泛应用以及医疗器材製造商在研发方面的大力投入，全球脑植入市场正经历快速成长。脑植入物（也称为神经植入物）是一种透过手术植入的装置，它透过电刺激大脑特定区域来治疗癫痫、帕金森氏症、阿兹海默症和精神分裂症等神经系统疾病。

2025年全球脑植入物市场价值23.6亿美元。预计该市场将从2026年的26.2亿美元成长到2034年的60.9亿美元，在预测期（2026-2034年）内复合年增长率高达12.80%。北美在2025年占全球市场主导地位，市占率达45.53%，这得益于其先进的医疗基础设施、高诊断率和有利的报销政策。

新冠疫情的影响

新冠疫情对脑植入物市场产生了短期负面影响。医院临时关闭、择期神经外科手术延迟以及患者就诊量减少显着减缓了市场成长。根据美国国家医学图书馆（2021年11月）的数据显示，疫情期间神经外科转诊量下降了33.6%，手术量下降了55.6%。

由于供应链中断和手术延迟，主要公司的收入有所下降。例如，波士顿科学公司（Boston Scientific）的神经调控部门2020年的收入为7.61亿美元，比2019年下降了12.8%。然而，随着手术恢復和患者数量的回升，市场在2021年开始復苏。

市场趋势

更重视柔性且先进的神经探针

脑植入物市场的主要趋势之一是开发柔性探针，以减少传统硅胶植入物造成的疤痕。研究机构正在探索丝素蛋白和藻酸盐等可弯曲材料，以匹配脑组织的柔软度。

2023年6月，格拉斯哥大学与我们合作，研究用于柔性脑探针的先进生物材料。此外，细胞疗法与生物电子学的融合正成为一项突破性趋势。 2023年3月，剑桥大学开发了一种神经植入物，可以帮助瘫痪患者恢復肢体功能。

市场成长驱动因素

神经系统疾病发生率上升

神经系统疾病发生率的上升是市场成长的主要驱动因素。根据世界卫生组织（2022年1月）的数据，全球有2400万人患有精神分裂症；阿兹海默症协会（2023年3月）报告称，美国有670万65岁及以上的老年人患有阿兹海默症，预计到2060年，这一数字将达到1380万。

提高公众意识的宣传活动、诊断率的提高以及医疗保健支出的成长，进一步推动了脑植入技术在全球的普及。

研发投入不断增加

医疗器材製造商正大力投资研发，以开发创新型个人化脑植入技术。 2023年1月，Precision Neuroscience宣布将专注于开发“第七层皮层介面”，以帮助瘫痪患者，这凸显了该市场由创新驱动的成长。

限制因子

儘管成长前景广阔，但新兴国家高昂的治疗费用和有限的保险覆盖范围阻碍了市场渗透。例如，在土耳其，一台深部脑部刺激设备的平均成本为 28,000 至 29,000 美元，这限制了低收入地区的患者获得治疗的机会。此外，医疗基础设施不发达和疾病认知度低也阻碍了市场渗透。

市场区隔分析

依产品划分

在获得多项 FDA 批准的推动下，深部脑部刺激疗法在 2026 年占了 65.60% 的市场占有率。迷走神经刺激预计将实现显着增长，而响应式神经刺激由于其个性化、即时治疗能力，预计将以最快的复合年增长率增长。

依应用领域划分

2024年，癫痫占市场主导地位，而帕金森氏症在2026年占33.94%的市场。由于患病率上升和新产品获批，阿兹海默症预计将以更高的复合年增长率增长。

依最终使用者划分

2026年，医院以73.35%的市占率领先，这主要是由于外科手术数量的增加和神经系统护理基础设施的改善。

区域洞察

  • 北美：预计2025年市场规模将达10.7亿美元。美国预计到2026年将达到10.4亿美元。 2026年
  • 欧洲：由于健保报销体系和教育举措，预计成长强劲。
  • 亚太地区：由于人口老化和高性价比植入物，预计复合年增长率最高。
  • 世界其他地区（ROW）：由于神经系统疾病治疗服务可近性的提高，预计将成长。

主要行业参与者

主要参与者包括美敦力、波士顿科学、雅培、Neuropace、LivaNova PLC 和 Areva NeuroTherapeutics。美敦力凭藉其强大的产品阵容和研发投入，在市场中处于领先地位。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 各国和地区主要神经系统疾病盛行率（2025 年）
  • 主要公司新产品发布
  • 主要产业趋势：併购、业务合作
  • 脑植入技术进步
  • 主要地区的监管状况
  • 新冠疫情的影响市场

第五章 全球脑植入市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依产品分类
    • 深部脑部刺激
    • 迷走神经刺激
    • 反应性神经刺激
  • 市场分析、洞察与预测：依应用分类
    • 癫痫
    • 帕金森氏症
    • 阿兹海默症
    • 精神分裂症
    • 其他
  • 市场分析、洞察与预测：依最终用户分类
    • 医院
    • 专科诊所
    • 其他
  • 市场分析、洞察与预测：依地区分类
    • 北美美洲
    • 欧洲
    • 亚太地区
    • 世界其他地区 (ROW)

第六章 北美脑植入市场分析：洞察与预测 (2021-2034)

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲脑植入市场分析：洞察与预测 (2021-2034)

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章 亚太脑植入市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章：世界其他地区（ROW）脑植入市场分析：洞察与预测（2021-2034）

第10章 竞争分析

  • 全球市场占有率分析(2025年)
  • 企业简介
    • Boston Scientific Corporation(U.S.)
    • Medtronic(Ireland)
    • Abbott(U.S.)
    • NeuroPace, Inc.(U.S.)
    • NDI Medical, LLC(U.S.)
    • ALEVA NEUROTHERAPEUTICS(Switzerland)
    • LivaNova PLC.(U.K.)
Product Code: FBI105021

Growth Factors of brain implants Market

The global brain implants market is witnessing rapid growth due to the rising prevalence of neurological disorders, increasing adoption of advanced neuromodulation therapies, and strong investments in research and development by medical device manufacturers. Brain implants, also known as neural implants, are surgically implanted devices that electrically stimulate specific regions of the brain to manage neurological conditions such as epilepsy, Parkinson's disease, Alzheimer's disease, and schizophrenia.

In 2025, the global brain implants market size was valued at USD 2.36 billion. The market is projected to grow from USD 2.62 billion in 2026 to USD 6.09 billion by 2034, exhibiting a strong CAGR of 12.80% during the forecast period (2026-2034). North America dominated the global market with a 45.53% share in 2025, supported by advanced healthcare infrastructure, high diagnosis rates, and favorable reimbursement policies.

COVID-19 Impact

The COVID-19 pandemic had a negative short-term impact on the brain implants market. Temporary hospital shutdowns, postponement of elective neurosurgeries, and reduced patient visits significantly slowed market growth. According to the National Library of Medicine (November 2021), neurosurgical referrals declined by 33.6%, while operations dropped by 55.6% during the pandemic.

Key players experienced revenue declines due to supply chain disruptions and delayed procedures. For instance, Boston Scientific's neuromodulation segment recorded revenues of USD 761.0 million in 2020, reflecting a 12.8% decline from 2019. However, the market began recovering in 2021 with the resumption of surgeries and improved patient footfall.

Market Trends

Rising Focus on Flexible and Advanced Neural Probes

One of the key trends in the brain implants market is the development of flexible probes to reduce scarring caused by traditional silicon-based implants. Research institutions are exploring bendable materials such as silk fibroin and alginate to better match brain tissue softness.

In June 2023, the University of Glasgow collaborated on research exploring advanced biological materials for flexible brain probes. Additionally, the integration of cell therapy with bioelectronics is emerging as a breakthrough trend. In March 2023, the University of Cambridge developed a neural implant capable of restoring limb function in paralyzed patients.

Market Growth Drivers

Rising Prevalence of Neurological Disorders

The growing incidence of neurological disorders is a primary driver of market growth. According to WHO (January 2022), 24 million people globally suffer from schizophrenia, while Alzheimer's Association (March 2023) reported 6.7 million Americans aged 65+ living with Alzheimer's disease, projected to reach 13.8 million by 2060.

Awareness campaigns, improving diagnosis rates, and rising healthcare expenditure are further driving the adoption of brain implants globally.

Increasing R&D Investments

Medical device manufacturers are heavily investing in R&D to develop innovative and personalized brain implant technologies. In January 2023, Precision Neuroscience focused on developing the Layer 7 Cortical Interface to assist patients with paralysis, highlighting the innovation-driven growth of the market.

Restraining Factors

Despite strong growth prospects, high treatment costs and limited reimbursement in emerging economies restrict market adoption. For example, the average cost of a deep brain stimulation device ranges between USD 28,000 and USD 29,000 in Turkey, limiting accessibility in low-income regions. Additionally, poor healthcare infrastructure and limited disease awareness further restrain market penetration.

Segmentation Analysis

By Product

Deep brain stimulation dominated the market with a 65.60% share in 2026, owing to multiple FDA approvals. Vagus nerve stimulation is expected to grow significantly, while responsive neurostimulation is projected to expand at the fastest CAGR due to personalized, real-time treatment capabilities.

By Application

Epilepsy dominated the market in 2024, while Parkinson's disease accounted for 33.94% share in 2026. Alzheimer's disease is expected to grow at a higher CAGR due to rising prevalence and new product approvals.

By End-user

Hospitals led the market with a 73.35% share in 2026, driven by higher surgical volumes and improved neurological care infrastructure.

Regional Insights

  • North America: Generated USD 1.07 billion in 2025; U.S. projected to reach USD 1.04 billion by 2026
  • Europe: Strong growth supported by reimbursement and awareness initiatives
  • Asia Pacific: Fastest CAGR due to aging population and cost-effective implants
  • Rest of the World: Growth driven by improved access to neurological care

Key Industry Players

Major players include Medtronic, Boston Scientific Corporation, Abbott, NeuroPace, LivaNova PLC, and ALEVA Neurotherapeutics. Medtronic leads the market with strong product offerings and R&D investments.

Conclusion

The global brain implants market is poised for robust growth, expanding from USD 2.36 billion in 2025 to USD 6.09 billion by 2034, driven by the rising prevalence of neurological disorders, increasing adoption of neuromodulation therapies, and strong R&D investments by key players. Although high treatment costs and limited reimbursement in emerging economies pose challenges, ongoing technological advancements, growing awareness, and expanding healthcare infrastructure are expected to support sustained market expansion over the forecast period.

Segmentation By Product

  • Deep Brain Stimulation
  • Vagus Nerve Stimulation
  • Responsive Neurostimulation

By Application

  • Epilepsy
  • Parkinson's Disease
  • Alzheimer's Disease
  • Schizophrenia
  • Others

By End-user

  • Hospitals
  • Specialty Clinics
  • Others

By Region

  • North America (By Product, By Application, By End-user, By Country)
    • U.S.
    • Canada
  • Europe (By Product, By Application, By End-user, By Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product, By Application, By End-user, By Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of the Asia Pacific
  • Rest of the World (By Product, By Application, By End-user)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Neurological Disorders, By Key Countries/Regions, 2025
  • 4.2. New Product Launches, By Key Players
  • 4.3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  • 4.4. Technological Advancements in Brain Implants
  • 4.5. Regulatory Scenario, Key Regions
  • 4.6. Impact of COVID-19 on the Market

5. Global Brain Implants Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Deep Brain Stimulation
    • 5.1.2. Vagus Nerve Stimulation
    • 5.1.3. Responsive Neurostimulation
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Epilepsy
    • 5.2.2. Parkinson's Disease
    • 5.2.3. Alzheimer's Disease
    • 5.2.4. Schizophrenia
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals
    • 5.3.2. Specialty Clinics
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Rest of the World

6. North America Brain Implants Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Deep Brain Stimulation
    • 6.1.2. Vagus Nerve Stimulation
    • 6.1.3. Responsive Neurostimulation
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Epilepsy
    • 6.2.2. Parkinson's Disease
    • 6.2.3. Alzheimer's Disease
    • 6.2.4. Schizophrenia
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals
    • 6.3.2. Specialty Clinics
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Brain Implants Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Deep Brain Stimulation
    • 7.1.2. Vagus Nerve Stimulation
    • 7.1.3. Responsive Neurostimulation
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Epilepsy
    • 7.2.2. Parkinson's Disease
    • 7.2.3. Alzheimer's Disease
    • 7.2.4. Schizophrenia
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals
    • 7.3.2. Specialty Clinics
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Brain Implants Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Deep Brain Stimulation
    • 8.1.2. Vagus Nerve Stimulation
    • 8.1.3. Responsive Neurostimulation
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Epilepsy
    • 8.2.2. Parkinson's Disease
    • 8.2.3. Alzheimer's Disease
    • 8.2.4. Schizophrenia
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals
    • 8.3.2. Specialty Clinics
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of the Asia Pacific

9. Rest of the World Brain Implants Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Deep Brain Stimulation
    • 9.1.2. Vagus Nerve Stimulation
    • 9.1.3. Responsive Neurostimulation
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Epilepsy
    • 9.2.2. Parkinson's Disease
    • 9.2.3. Alzheimer's Disease
    • 9.2.4. Schizophrenia
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals
    • 9.3.2. Specialty Clinics
    • 9.3.3. Others

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles
    • 10.2.1. Boston Scientific Corporation (U.S.)
      • 10.2.1.1. Overview
      • 10.2.1.2. SWOT Analysis
      • 10.2.1.3. Recent Developments
      • 10.2.1.4. Strategies
      • 10.2.1.5. financials (Based on Availability)
    • 10.2.2. Medtronic (Ireland)
      • 10.2.2.1. Overview
      • 10.2.2.2. SWOT Analysis
      • 10.2.2.3. Recent Developments
      • 10.2.2.4. Strategies
      • 10.2.2.5. financials (Based on Availability)
    • 10.2.3. Abbott (U.S.)
      • 10.2.3.1. Overview
      • 10.2.3.2. SWOT Analysis
      • 10.2.3.3. Recent Developments
      • 10.2.3.4. Strategies
      • 10.2.3.5. financials (Based on Availability)
    • 10.2.4. NeuroPace, Inc. (U.S.)
      • 10.2.4.1. Overview
      • 10.2.4.2. SWOT Analysis
      • 10.2.4.3. Recent Developments
      • 10.2.4.4. Strategies
      • 10.2.4.5. financials (Based on Availability)
    • 10.2.5. NDI Medical, LLC (U.S.)
      • 10.2.5.1. Overview
      • 10.2.5.2. SWOT Analysis
      • 10.2.5.3. Recent Developments
      • 10.2.5.4. Strategies
      • 10.2.5.5. financials (Based on Availability)
    • 10.2.6. ALEVA NEUROTHERAPEUTICS (Switzerland)
      • 10.2.6.1. Overview
      • 10.2.6.2. SWOT Analysis
      • 10.2.6.3. Recent Developments
      • 10.2.6.4. Strategies
      • 10.2.6.5. financials (Based on Availability)
    • 10.2.7. LivaNova PLC. (U.K.)
      • 10.2.7.1. Overview
      • 10.2.7.2. SWOT Analysis
      • 10.2.7.3. Recent Developments
      • 10.2.7.4. Strategies
      • 10.2.7.5. financials (Based on Availability)

List of Tables

  • Table 1: Global Brain Implants Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 2: Global Brain Implants Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 3: Global Brain Implants Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 4: Global Brain Implants Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 5: North America Brain Implants Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 6: North America Brain Implants Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 7: North America Brain Implants Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 8: North America Brain Implants Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 9: Europe Brain Implants Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 10: Europe Brain Implants Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: Europe Brain Implants Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 12: Europe Brain Implants Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Brain Implants Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 14: Asia Pacific Brain Implants Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 15: Asia Pacific Brain Implants Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 16: Asia Pacific Brain Implants Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Rest of the World Brain Implants Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 18: Rest of the World Brain Implants Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 19: Rest of the World Brain Implants Market Revenue (USD billion) Forecast, by End-user, 2021-2034

List of Figures

  • Figure 1: Global Brain Implants Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Brain Implants Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Brain Implants Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Brain Implants Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Brain Implants Market Value (USD billion), by Region, 2025 & 2034
  • Figure 6: North America Brain Implants Market Value (USD billion), by Product, 2025 & 2034
  • Figure 7: North America Brain Implants Market Value Share (%), by Product, 2025
  • Figure 8: North America Brain Implants Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Brain Implants Market Value Share (%), by Application, 2025
  • Figure 10: North America Brain Implants Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 11: North America Brain Implants Market Value Share (%), by End-user, 2025
  • Figure 12: North America Brain Implants Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Brain Implants Market Value Share (%), By Country, 2025
  • Figure 14: Europe Brain Implants Market Value (USD billion), by Product, 2025 & 2034
  • Figure 15: Europe Brain Implants Market Value Share (%), by Product, 2025
  • Figure 16: Europe Brain Implants Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Brain Implants Market Value Share (%), by Application, 2025
  • Figure 18: Europe Brain Implants Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 19: Europe Brain Implants Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Brain Implants Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Brain Implants Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Brain Implants Market Value (USD billion), by Product, 2025 & 2034
  • Figure 23: Asia Pacific Brain Implants Market Value Share (%), by Product, 2025
  • Figure 24: Asia Pacific Brain Implants Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Brain Implants Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Brain Implants Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Brain Implants Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific Brain Implants Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Brain Implants Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Rest of the World Brain Implants Market Value (USD billion), by Product, 2025 & 2034
  • Figure 31: Rest of the World Brain Implants Market Value Share (%), by Product, 2025
  • Figure 32: Rest of the World Brain Implants Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Rest of the World Brain Implants Market Value Share (%), by Application, 2025
  • Figure 34: Rest of the World Brain Implants Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 35: Rest of the World Brain Implants Market Value Share (%), by End-user, 2025
  • Figure 36: Global Brain Implants Market Share (%), By Company, 2025